EMA tells countries to prioritise weight loss drugs for patients ‘with greatest need’ A European Medicines Agency steering group has asked member countries to work with marketing authorisation holders to “control and optimise the distribution” of glucagon-like peptide-1 receptor agonists.…
Bariatric surgery more effective than GLP-1 agonist weight loss drugs, study finds Weight loss from bariatric surgery was maintained at approximately 25% for up to ten years after surgery, while patients who received GLP-1 receptor agonists regained 50% of the weight lost within one year of stopping treatment.…
Type 2 diabetes remission achieved in 6% of patients through weight loss alone, study results show Experts have emphasised the importance of individualised treatment, which may include a low-calorie diet.…
Pharmacies to provide ‘dispense and delivery service’ for weight loss management pilots Community pharmacies will be part of a £40m pilot scheme that will run across several integrated care boards in England.…
MHRA warns of dangers of fake weight loss pens after Yellow Card reports The medicines regulator said Ozempic and Saxenda pens have been confirmed as being falsified with insulin in five of the reports.…
Semaglutide reduces cardiovascular events in adults who are overweight by 20%, study finds Trial results show fewer deaths from cardiovascular events, as well as non-fatal heart attacks and strokes, in patients who received semaglutide versus those who received placebo.…
Tirzepatide approved for weight loss treatment by regulator The Medicines and Healthcare products Regulatory Agency has said tirzepatide will be available to patients with obesity, or who are overweight, with weight-related health problems.…
UK regulator seizes 369 potentially fake weight loss pens following reports of hospitalisations The Medicines and Healthcare products Regulatory Agency said the public should consult a healthcare professional qualified to provide semaglutide and liraglutide via prescription.…
‘Limited’ supply of weight loss drug semaglutide launched in UK Manufacturer Novo Nordisk said it will monitor demand and work with regulators to ensure Wegovy is accessible to eligible patients.…
GPs to prescribe weight loss injections under £40m pilot scheme The GP-prescribing pilot is aimed to explore how drugs can be made available to more people by expanding specialist weight management services outside hospital settings.…
